Filtros de búsqueda

Lista de obras de James Lewis Abbruzzese

5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer

artículo científico publicado en 2005

A Novel, Clinically Relevant Animal Model of Metastatic Pancreatic Adenocarcinoma Biology and Therapy ⬇️

artículo científico publicado el 1 de enero de 2001

A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study

artículo científico publicado en 2006

A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis

artículo científico publicado en 2003

A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer

artículo científico publicado en 2005

A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumors

artículo científico publicado el 1 de mayo de 2012

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2008

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer

scientific article published on 27 January 2010

ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer

artículo científico publicado en 2015

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma ⬇️

artículo científico publicado el 13 de junio de 2011

AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.

artículo científico publicado en 2005

Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation

artículo científico

Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma

artículo científico

Adjuvant therapy for pancreatic cancer: current status and future directions

artículo científico publicado en 2004

Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells

artículo científico publicado en 2006

Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals ⬇️

artículo científico publicado el 12 de febrero de 2011

Association between hepatitis B virus and pancreatic cancer

artículo científico publicado en 2008

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States

artículo científico publicado en 2009

Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.

artículo científico publicado en 2011

Association of diabetes and perineural invasion in pancreatic cancer.

artículo científico publicado en 2012

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

artículo científico publicado en 2010

Association of multi‐drug resistance gene polymorphisms with pancreatic cancer outcome ⬇️

artículo científico publicado el 4 de octubre de 2010

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

scientific article published on 09 April 2011

Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic Cancer ⬇️

artículo científico publicado el 25 de febrero de 2011

Body mass index and risk, age of onset, and survival in patients with pancreatic cancer

artículo científico publicado en 2009

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

artículo científico publicado en 2006

Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells

artículo científico publicado en 2005

Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis

artículo científico publicado en 2005

Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.

artículo científico publicado en 2005

Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions

scientific article published on 01 June 2008

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

artículo científico publicado en 2004

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial

artículo científico publicado en 2004

Chemotherapy and radiation of anal canal cancer: the first approach

artículo científico publicado en 2004

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma

artículo científico publicado en 2011

Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma

artículo científico publicado en 2013

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated

artículo científico publicado en 2006

Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells

artículo científico publicado en 2015

Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions

artículo científico publicado en 2006

DNA Mismatch Repair Gene Polymorphisms Affect Survival in Pancreatic Cancer ⬇️

artículo científico publicado el 6 de enero de 2011

DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer ⬇️

artículo científico publicado el 16 de junio de 2011

DNA repair gene polymorphisms and risk of pancreatic cancer

artículo científico publicado en 2009

Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells ⬇️

artículo científico publicado el 22 de enero de 2013

Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?

artículo científico publicado en 2007

Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma

artículo científico publicado en 2014

Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer

artículo científico publicado en 2008

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.

artículo científico publicado en 2017

Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.

artículo científico publicado en 2005

Diagnostic protein discovery using proteolytic peptide targeting and identification

artículo científico publicado en 2004

Diagnostic strategies for unknown primary cancer

artículo científico publicado en 2004

Dietary mutagen exposure and risk of pancreatic cancer

artículo científico publicado en 2007

Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution

artículo científico publicado en 2007

Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients

artículo científico publicado en 2006

Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery

artículo científico publicado en 2005

Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model

artículo científico publicado en 2005

Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor

artículo científico publicado en 2006

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study

artículo científico publicado en 2008

Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer

artículo científico publicado en 2008

Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer

artículo científico publicado en 2011

Effects of base excision repair gene polymorphisms on pancreatic cancer survival

artículo científico publicado en 2007

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

artículo científico publicado en 2009

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer

artículo científico publicado el 1 de abril de 2011

Experimental animal models of pancreatic carcinogenesis and metastasis

artículo científico publicado en 2003

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma

artículo científico publicado en 2008

Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma

artículo científico publicado en 2015

Function of nuclear factor kappaB in pancreatic cancer metastasis

artículo científico publicado en 2003

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

artículo científico publicado en 2010

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

artículo científico publicado en 2009

Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction

artículo científico publicado en 2013

Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer ⬇️

artículo científico publicado el 16 de marzo de 2011

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer ⬇️

artículo científico publicado el 15 de septiembre de 2010

Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer

artículo científico publicado en 2007

High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.

artículo científico publicado en 2010

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma ⬇️

artículo científico publicado el 25 de octubre de 2011

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation ⬇️

artículo científico publicado el 16 de diciembre de 2011

I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score ⬇️

artículo científico publicado el 3 de agosto de 2011

Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer

artículo científico publicado en 2015

In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer

article

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

scientific article published on 01 July 2007

Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice

artículo científico publicado en 2005

Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model

artículo científico publicado en 2006

Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis

artículo científico publicado en 2003

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

artículo científico publicado en 2010

Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer

artículo científico publicado en 2010

Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer ⬇️

artículo científico publicado el 17 de agosto de 2011

Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer

artículo científico publicado en 2014

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival

artículo científico publicado en 2006

Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.

artículo científico publicado en 2003

Introducing new strategies in...

artículo científico publicado en 2010

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

artículo científico publicado en 2002

K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking

artículo científico publicado en 2007

LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

artículo científico publicado en 2008

Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk

artículo científico publicado en 2007

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma

artículo científico publicado en 2009

Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma ⬇️

artículo científico publicado el 20 de diciembre de 2012

Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death

artículo científico publicado en 2007

Metastatic patterns in adenocarcinoma

artículo científico publicado en 2006

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

artículo científico publicado en 2012

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

artículo científico publicado en 2013

Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification

artículo científico publicado en 2013

Multimodality Therapy Offers a Chance for Cure in Patients with Pancreatic Adenocarcinoma Deemed Unresectable at First Operative Exploration ⬇️

artículo científico publicado el 18 de mayo de 2012

NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells

artículo científico publicado en 2004

New option for the initial management of metastatic pancreatic cancer?

artículo científico publicado en 2014

New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts

artículo científico publicado en 2010

Novel therapies for pancreatic adenocarcinoma

artículo científico publicado en 2004

Novel therapies for pancreatic adenocarcinoma

artículo científico publicado en 2004

Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin

artículo científico publicado en 2005

Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS

Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet

artículo científico publicado en 2019

Opportunities for targeted therapies in hepatocellular carcinoma

artículo científico publicado en 2005

Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma ⬇️

artículo científico publicado el 4 de junio de 2012

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma ⬇️

artículo científico publicado el 4 de octubre de 2010

Overexpression of synuclein-gamma in pancreatic adenocarcinoma

artículo científico publicado en 2004

Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.

artículo científico publicado en 2005

Pancreatic cancer mortality in Egypt: comparison to the United States pancreatic cancer mortality rates.

artículo científico publicado en 2006

Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma

artículo científico publicado en 2013

Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study

artículo científico publicado en 2007

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis

artículo científico publicado en 2011

Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation

artículo científico publicado en 2007

Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma ⬇️

artículo científico publicado el 1 de marzo de 2012

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

artículo científico publicado en 2008

Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

artículo científico publicado en 2010

Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumors

artículo científico publicado en 2003

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.

artículo científico publicado en 2002

Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer

artículo científico publicado en 2006

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

artículo científico publicado en 2004

Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer ⬇️

artículo científico publicado el 1 de abril de 2003

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression ⬇️

artículo científico publicado el 27 de junio de 2011

Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma

artículo científico publicado en 2003

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

artículo científico publicado en 2006

Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma

artículo científico publicado en 2004

Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy

artículo científico publicado en 2002

Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer

scientific article published on 01 October 2002

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

scientific article published on 01 May 2006

Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers

artículo científico publicado en 2005

Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins

artículo científico publicado en 2005

Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes

artículo científico publicado en 2006

Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation ⬇️

artículo científico publicado el 6 de julio de 2011

Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I

artículo científico publicado en 2002

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

artículo científico publicado en 2016

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

artículo científico publicado en 2008

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

artículo científico publicado en 2008

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

artículo científico publicado en 2002

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

artículo científico publicado en 2006

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma

scientific article published on 19 September 2013

Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases

artículo científico publicado en 2007

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

artículo científico publicado en 2011

Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer

artículo científico publicado en 2009

Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.

artículo científico publicado en 2004

RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.

artículo científico publicado en 2015

Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas

artículo científico publicado en 2005

Reassessing hepatocellular carcinoma staging in a changing patient population

artículo científico publicado en 2014

Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells

artículo científico publicado en 2007

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

artículo científico publicado en 2012

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

artículo científico publicado en 2002

Risk factors for pancreatic cancer: case-control study

artículo científico publicado en 2007

SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms

artículo científico publicado en 2013

Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.

artículo científico publicado en 2006

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer

artículo científico publicado en 2017

Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation

artículo científico publicado en 2010

Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer.

artículo científico publicado en 2005

Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer

scientific article published on 23 February 2009

Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival

artículo científico publicado en 2006

Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.

artículo científico publicado en 2005

Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer

artículo científico publicado en 2006

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity

artículo científico publicado en 2009

Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer

artículo científico publicado en 2008

Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells ⬇️

artículo científico publicado el 8 de noviembre de 2012

Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution

artículo científico publicado en 2014

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

artículo científico publicado en 2018

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

artículo científico publicado en 2003

Stemming the tide of hepatitis B virus related hepatocellular carcinoma?

artículo científico publicado en 2008

Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant

artículo científico publicado en 2005

Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells

artículo científico publicado en 2002

Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells

artículo científico publicado en 2006

Systematic Survey of Therapeutic Trials for Metastatic Colorectal Cancer: Room for Improvement in the Critical Pathway.

artículo científico publicado en 2008

Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway

artículo científico publicado en 2008

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models

scientific article published on 01 July 2007

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial

artículo científico publicado en 2005

The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1

artículo científico publicado en 2014

The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

artículo científico publicado en 2018

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells

artículo científico publicado en 2004

The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk

artículo científico publicado en 2006

The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer

artículo científico publicado en 2013

The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States

artículo científico publicado en 2008

The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy

artículo científico publicado en 2013

The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation

artículo científico publicado en 2005

The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells

artículo científico publicado en 2005

The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis

artículo científico publicado en 2011

Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells

artículo científico publicado en 2008

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

artículo científico publicado en 2009

Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines

artículo científico publicado en 2006

Transport properties of pancreatic cancer describe gemcitabine delivery and response

scientific article published on 10 March 2014

Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival

artículo científico publicado en 2013

Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy ⬇️

artículo científico publicado el 1 de abril de 2012

Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt

artículo científico publicado en 2002

Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed? ⬇️

artículo científico publicado el 5 de noviembre de 2012

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials

artículo científico publicado en 2010

XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda